Cargando…

Testing for association of the monoamine oxidase A promoter polymorphism with brain structure volumes in both autism and the fragile X syndrome

BACKGROUND: Autism and the fragile X syndrome (FXS) are related to each other genetically and symptomatically. A cardinal biological feature of both disorders is abnormalities of cerebral cortical brain volumes. We have previously shown that the monoamine oxidase A (MAOA) promoter polymorphism is as...

Descripción completa

Detalles Bibliográficos
Autores principales: Wassink, Thomas H, Hazlett, Heather C, Davis, Lea K, Reiss, Allan L, Piven, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987046/
https://www.ncbi.nlm.nih.gov/pubmed/24669826
http://dx.doi.org/10.1186/1866-1955-6-6
_version_ 1782311821779140608
author Wassink, Thomas H
Hazlett, Heather C
Davis, Lea K
Reiss, Allan L
Piven, Joseph
author_facet Wassink, Thomas H
Hazlett, Heather C
Davis, Lea K
Reiss, Allan L
Piven, Joseph
author_sort Wassink, Thomas H
collection PubMed
description BACKGROUND: Autism and the fragile X syndrome (FXS) are related to each other genetically and symptomatically. A cardinal biological feature of both disorders is abnormalities of cerebral cortical brain volumes. We have previously shown that the monoamine oxidase A (MAOA) promoter polymorphism is associated with cerebral cortical volumes in children with autism, and we now sought to determine whether the association was also present in children with FXS. METHODS: Participants included 47 2-year-old Caucasian boys with FXS, some of whom also had autism, as well as 34 2-year-old boys with idiopathic autism analyzed in a previous study. The MAOA promoter polymorphism was genotyped and tested for relationships with gray and white matter volumes of the cerebral cortical lobes and cerebro-spinal fluid volume of the lateral ventricles. RESULTS: MAOA genotype effects in FXS children were the same as those previously observed in idiopathic autism: the low activity MAOA promoter polymorphism allele was associated with increased gray and white matter volumes in all cerebral lobes. The effect was most pronounced in frontal lobe gray matter and all three white matter regions: frontal gray, F = 4.39, P = 0.04; frontal white, F = 5.71, P = 0.02; temporal white, F = 4.73, P = 0.04; parieto-occipital white, F = 5.00, P = 0.03. Analysis of combined FXS and idiopathic autism samples produced P values for these regions <0.01 and effect sizes of approximately 0.10. CONCLUSIONS: The MAOA promoter polymorphism is similarly associated with brain structure volumes in both idiopathic autism and FXS. These data illuminate a number of important aspects of autism and FXS heritability: a genetic effect on a core biological trait of illness, the specificity/generalizability of the genetic effect, and the utility of examining individual genetic effects on the background of a single gene disorder such as FXS.
format Online
Article
Text
id pubmed-3987046
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39870462014-04-16 Testing for association of the monoamine oxidase A promoter polymorphism with brain structure volumes in both autism and the fragile X syndrome Wassink, Thomas H Hazlett, Heather C Davis, Lea K Reiss, Allan L Piven, Joseph J Neurodev Disord Research BACKGROUND: Autism and the fragile X syndrome (FXS) are related to each other genetically and symptomatically. A cardinal biological feature of both disorders is abnormalities of cerebral cortical brain volumes. We have previously shown that the monoamine oxidase A (MAOA) promoter polymorphism is associated with cerebral cortical volumes in children with autism, and we now sought to determine whether the association was also present in children with FXS. METHODS: Participants included 47 2-year-old Caucasian boys with FXS, some of whom also had autism, as well as 34 2-year-old boys with idiopathic autism analyzed in a previous study. The MAOA promoter polymorphism was genotyped and tested for relationships with gray and white matter volumes of the cerebral cortical lobes and cerebro-spinal fluid volume of the lateral ventricles. RESULTS: MAOA genotype effects in FXS children were the same as those previously observed in idiopathic autism: the low activity MAOA promoter polymorphism allele was associated with increased gray and white matter volumes in all cerebral lobes. The effect was most pronounced in frontal lobe gray matter and all three white matter regions: frontal gray, F = 4.39, P = 0.04; frontal white, F = 5.71, P = 0.02; temporal white, F = 4.73, P = 0.04; parieto-occipital white, F = 5.00, P = 0.03. Analysis of combined FXS and idiopathic autism samples produced P values for these regions <0.01 and effect sizes of approximately 0.10. CONCLUSIONS: The MAOA promoter polymorphism is similarly associated with brain structure volumes in both idiopathic autism and FXS. These data illuminate a number of important aspects of autism and FXS heritability: a genetic effect on a core biological trait of illness, the specificity/generalizability of the genetic effect, and the utility of examining individual genetic effects on the background of a single gene disorder such as FXS. BioMed Central 2014 2014-03-26 /pmc/articles/PMC3987046/ /pubmed/24669826 http://dx.doi.org/10.1186/1866-1955-6-6 Text en Copyright © 2014 Wassink et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research
Wassink, Thomas H
Hazlett, Heather C
Davis, Lea K
Reiss, Allan L
Piven, Joseph
Testing for association of the monoamine oxidase A promoter polymorphism with brain structure volumes in both autism and the fragile X syndrome
title Testing for association of the monoamine oxidase A promoter polymorphism with brain structure volumes in both autism and the fragile X syndrome
title_full Testing for association of the monoamine oxidase A promoter polymorphism with brain structure volumes in both autism and the fragile X syndrome
title_fullStr Testing for association of the monoamine oxidase A promoter polymorphism with brain structure volumes in both autism and the fragile X syndrome
title_full_unstemmed Testing for association of the monoamine oxidase A promoter polymorphism with brain structure volumes in both autism and the fragile X syndrome
title_short Testing for association of the monoamine oxidase A promoter polymorphism with brain structure volumes in both autism and the fragile X syndrome
title_sort testing for association of the monoamine oxidase a promoter polymorphism with brain structure volumes in both autism and the fragile x syndrome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987046/
https://www.ncbi.nlm.nih.gov/pubmed/24669826
http://dx.doi.org/10.1186/1866-1955-6-6
work_keys_str_mv AT wassinkthomash testingforassociationofthemonoamineoxidaseapromoterpolymorphismwithbrainstructurevolumesinbothautismandthefragilexsyndrome
AT hazlettheatherc testingforassociationofthemonoamineoxidaseapromoterpolymorphismwithbrainstructurevolumesinbothautismandthefragilexsyndrome
AT davisleak testingforassociationofthemonoamineoxidaseapromoterpolymorphismwithbrainstructurevolumesinbothautismandthefragilexsyndrome
AT reissallanl testingforassociationofthemonoamineoxidaseapromoterpolymorphismwithbrainstructurevolumesinbothautismandthefragilexsyndrome
AT pivenjoseph testingforassociationofthemonoamineoxidaseapromoterpolymorphismwithbrainstructurevolumesinbothautismandthefragilexsyndrome